LEXICON PHARMACEUTICAL

Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions

25 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the 2021 Jefferies Virtual Healthcare Conference

26 May 2021 15:15:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology’s 70th Annual Scientific Session

13 May 2021 15:15:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update

06 May 2021 15:05:01 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021

29 Apr 2021 15:13:55 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference

08 Apr 2021 15:35:10 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update

10 Mar 2021 15:10:22 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021

04 Mar 2021 15:05:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure

14 Jan 2021 07:00:02 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the 39th Annual J.P. Morgan Healthcare Conference

06 Jan 2021 07:00:01 By Nasdaq GlobeNewswire